AI assistant
Relx PLC Director's Dealing 2025
5248_dirs_2025-02-19_b2fbe51d-2bf6-49df-aff5-337822bc0d36.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 6004X
RELX PLC
19 February 2025
ISSUED ON BEHALF OF RELX PLC
Director/ PDMR Shareholdings
Following the completion of the transactions set out in this announcement, together with the transactions disclosed on the announcement dated 18 February 2025 (yesterday), Erik Engstrom, Chief Executive Officer holds 1,180,001 RELX PLC Ordinary Shares/ ADRs (1,175,520 PLC Ordinary Shares/ADRs held before these transactions).
RELX PLC
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
| a) | Name | Erik Engstrom | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | PDMR | |||
| b) | Initial notification /Amendment | Initial Notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | RELX PLC | |||
| b) | LEI | 549300WSX3VBUFFJOO66 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument | American Depositary Receipts in RELX PLC ('ADRs'). Each ADR represents one Ordinary Shares in RELX PLC of 14 51/116p each ('Ordinary Shares') |
|||
| Identification code | ISIN: US7595301083 | ||||
| b) | Nature of the transaction | Sale of ADRs | |||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) | ||||
| $50.905774 | 20,250 | ||||
| d) | Aggregated information | ||||
| - Aggregated volume | 20,250 | ||||
| - Price | $50.905774 | ||||
| e) | Date of the transaction | 2025-02-18 | |||
| f) | Place of the transaction | New York Stock Exchange |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFFFELFAITLIE